A team of University of Maryland scientists has paved the way for the development of new drug therapies to combat active and asymptomatic (latent) tuberculosis infections by characterizing the unique structure and mechanism of an enzyme in M. tuberculosis, the bacterium that causes the disease.
MicrobeWorld App
Watch Live Events
Featured Image
Featured Video
Supporters
Discovery Of Tuberculosis Bacterium Enzyme Paves Way For New TB Drugs
American Society for Microbiology
2012 1752 N Street, N.W. • Washington, DC 20036-2904 • (202) 737-3600
Copyright © American Center for Microbiology 2012. All Rights Reserved.
